The World Market for Vaccines, Antisera, and Other Blood Fractions: A 2009 Global Trade Perspective
ICON Group International, September 2008, Pages: 223
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for vaccines, antisera, and other blood fractions. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for vaccines, antisera, and other blood fractions for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying vaccines, antisera, and other blood fractions? What is the dollar value of these imports? How much do the imports of vaccines, antisera, and other blood fractions vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of vaccines, antisera, and other blood fractions? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported vaccines, antisera, and other blood fractions. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of vaccines, antisera, and other blood fractions, for each individual country. Chapter 4 does the same, but for imports of vaccines, antisera, and other blood fractions for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of vaccines, antisera, and other blood fractions to and from all major countries in the world. Of the 150 countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in vaccines, antisera, and other blood fractions (i.e. their market shares are close or equal to zero percent). "Vaccines, Antisera, and Other Blood Fractions" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "vaccines, antisera, and other blood fractions" is 54163 .
1 METHODOLOGY 10
1.1 Our Approach 10
2 THE WORLD MARKET 13
2.1 Exports 13
2.1.1 The World Market: Vaccines, Antisera, and Other Blood Fractions Export Supplies in 2009 13
2.2 Imports 15
2.2.1 The World Market: Imported Vaccines, Antisera, and Other Blood Fractions in 2009 15
3 EXPORTS 19
3.1 Africa: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 19
3.1.1 Executive Summary 19
3.1.2 Botswana 21
3.1.3 Egypt 21
3.1.4 Kenya 22
3.1.5 Morocco 22
3.1.6 Senegal 22
3.1.7 South Africa 23
3.1.8 Swaziland 24
3.1.9 Tunisia 24
3.1.10 Zambia 24
3.1.11 Zimbabwe 24
3.2 Asia: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 25
3.2.1 Executive Summary 25
3.2.2 Bangladesh 27
3.2.3 China 28
3.2.4 Hong Kong 29
3.2.5 India 30
3.2.6 Indonesia 31
3.2.7 Japan 32
3.2.8 Malaysia 33
3.2.9 Nepal 33
3.2.10 North Korea 33
3.2.11 Philippines 34
3.2.12 Singapore 34
3.2.13 South Korea 35
3.2.14 Taiwan 36
3.2.15 Thailand 36
3.2.16 Vietnam 37
3.3 Europe: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 37
3.3.1 Executive Summary 37
3.3.2 Austria 41
3.3.3 Belarus 42
3.3.4 Belgium 43
3.3.5 Bulgaria 44
3.3.6 Croatia 44
3.3.7 Cyprus 45
3.3.8 Czech Republic 46
3.3.9 Denmark 47
3.3.10 Estonia 48
3.3.11 Finland 49
3.3.12 France 50
3.3.13 Georgia 51
3.3.14 Germany 52
3.3.15 Greece 53
3.3.16 Hungary 54
3.3.17 Iceland 55
3.3.18 Ireland 56
3.3.19 Italy 57
3.3.20 Kazakhstan 58
3.3.21 Latvia 58
3.3.22 Lithuania 58
3.3.23 Luxembourg 59
3.3.24 Macedonia 59
3.3.25 Norway 60
3.3.26 Poland 61
3.3.27 Portugal 61
3.3.28 Romania 62
3.3.29 Russia 62
3.3.30 Slovakia 63
3.3.31 Slovenia 63
3.3.32 Spain 64
3.3.33 Sweden 65
3.3.34 Switzerland 66
3.3.35 the Netherlands 67
3.3.36 the United Kingdom 68
3.3.37 Ukraine 69
3.4 Latin America: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 69
3.4.1 Executive Summary 69
3.4.2 Argentina 73
3.4.3 Belize 73
3.4.4 Brazil 74
3.4.5 Chile 75
3.4.6 Colombia 75
3.4.7 Costa Rica 76
3.4.8 Ecuador 76
3.4.9 El Salvador 76
3.4.10 Guatemala 77
3.4.11 Honduras 77
3.4.12 Mexico 78
3.4.13 Nicaragua 79
3.4.14 Panama 79
3.4.15 Paraguay 79
3.4.16 Peru 80
3.4.17 Uruguay 80
3.4.18 Venezuela 81
3.5 North America & the Caribbean: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 81
3.5.1 Executive Summary 81
3.5.2 Aruba 84
3.5.3 Canada 85
3.5.4 Cuba 86
3.5.5 the United States 87
3.5.6 Trinidad and Tobago 88
3.6 Oceana: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 88
3.6.1 Executive Summary 88
3.6.2 Australia 91
3.6.3 New Zealand 92
3.6.4 Vanuatu 93
3.7 the Middle East: Export Supplies of Vaccines, Antisera, and Other Blood Fractions 93
3.7.1 Executive Summary 93
3.7.2 Armenia 96
3.7.3 Iran 96
3.7.4 Israel 97
3.7.5 Jordan 98
3.7.6 Kyrgyzstan 98
3.7.7 Lebanon 98
3.7.8 Oman 99
3.7.9 Pakistan 99
3.7.10 Saudi Arabia 99
3.7.11 the United Arab Emirates 100
3.7.12 Turkey 100
4 IMPORTS 101
4.1 Africa: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 101
4.1.1 Executive Summary 101
4.1.2 Algeria 104
4.1.3 Botswana 105
4.1.4 Cameroon 105
4.1.5 Cape Verde 105
4.1.6 Cote dIvoire 106
4.1.7 Egypt 107
4.1.8 Ethiopia 108
4.1.9 Gabon 108
4.1.10 Ghana 109
4.1.11 Madagascar 109
4.1.12 Malawi 110
4.1.13 Mauritania 110
4.1.14 Mauritius 111
4.1.15 Morocco 112
4.1.16 Mozambique 112
4.1.17 Namibia 113
4.1.18 Senegal 113
4.1.19 South Africa 114
4.1.20 Sudan 115
4.1.21 Tanzania 115
4.1.22 Uganda 116
4.2 Asia: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 116
4.2.1 Executive Summary 116
4.2.2 Brunei 119
4.2.3 China 120
4.2.4 Hong Kong 121
4.2.5 India 122
4.2.6 Indonesia 123
4.2.7 Japan 124
4.2.8 Macau 125
4.2.9 Malaysia 126
4.2.10 Maldives 126
4.2.11 Mongolia 127
4.2.12 Philippines 128
4.2.13 Seychelles 129
4.2.14 Singapore 129
4.2.15 South Korea 130
4.2.16 Taiwan 131
4.2.17 Thailand 132
4.3 Europe: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 133
4.3.1 Executive Summary 133
4.3.2 Albania 136
4.3.3 Austria 137
4.3.4 Belarus 138
4.3.5 Belgium 139
4.3.6 Bosnia and Herzegovina 140
4.3.7 Bulgaria 141
4.3.8 Croatia 142
4.3.9 Cyprus 143
4.3.10 Czech Republic 144
4.3.11 Denmark 145
4.3.12 Estonia 146
4.3.13 Finland 147
4.3.14 France 148
4.3.15 Georgia 149
4.3.16 Germany 150
4.3.17 Greece 151
4.3.18 Hungary 152
4.3.19 Iceland 153
4.3.20 Ireland 154
4.3.21 Italy 155
4.3.22 Kazakhstan 156
4.3.23 Latvia 157
4.3.24 Lithuania 158
4.3.25 Luxembourg 159
4.3.26 Macedonia 159
4.3.27 Malta 160
4.3.28 Moldova 160
4.3.29 Norway 161
4.3.30 Poland 162
4.3.31 Portugal 163
4.3.32 Romania 164
4.3.33 Russia 165
4.3.34 Slovakia 166
4.3.35 Slovenia 167
4.3.36 Spain 168
4.3.37 Sweden 169
4.3.38 Switzerland 170
4.3.39 the Netherlands 171
4.3.40 the United Kingdom 172
4.3.41 Ukraine 173
4.4 Latin America: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 174
4.4.1 Executive Summary 174
4.4.2 Argentina 178
4.4.3 Belize 179
4.4.4 Bolivia 179
4.4.5 Brazil 180
4.4.6 Chile 181
4.4.7 Colombia 182
4.4.8 Costa Rica 183
4.4.9 Ecuador 184
4.4.10 El Salvador 185
4.4.11 Guatemala 186
4.4.12 Guyana 187
4.4.13 Honduras 187
4.4.14 Mexico 188
4.4.15 Nicaragua 189
4.4.16 Panama 190
4.4.17 Paraguay 191
4.4.18 Peru 192
4.4.19 Uruguay 193
4.4.20 Venezuela 194
4.5 North America & the Caribbean: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 194
4.5.1 Executive Summary 194
4.5.2 Barbados 197
4.5.3 Canada 198
4.5.4 Jamaica 199
4.5.5 St. Vincent and the Grenadines 199
4.5.6 the United States 200
4.5.7 Trinidad and Tobago 201
4.6 Oceana: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 201
4.6.1 Executive Summary 201
4.6.2 Australia 205
4.6.3 Fiji 206
4.6.4 New Caledonia 206
4.6.5 New Zealand 207
4.7 the Middle East: Vaccines, Antisera, and Other Blood Fractions Imports in 2009 207
4.7.1 Executive Summary 207
4.7.2 Armenia 210
4.7.3 Azerbaijan 211
4.7.4 Bahrain 211
4.7.5 Iran 212
4.7.6 Israel 213
4.7.7 Jordan 214
4.7.8 Kyrgyzstan 215
4.7.9 Oman 216
4.7.10 Pakistan 217
4.7.11 Qatar 218
4.7.12 Saudi Arabia 219
4.7.13 Syrian Arab Republic 220
4.7.14 Turkey 220
4.7.15 Yemen 221
5 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 222
5.1 Disclaimers & Safe Harbor 222
5.2 ICON Group Ltd. User Agreement Provisions 223
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
